Clinical trial

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

NCT00615459

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE3

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2011-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

IndacaterolDRUG

TiotropiumDRUG · verified · RxNorm: tiotropium

PlaceboDRUG

Sponsors & collaborators

Novartislead sponsor

Mapped research locations

MadridSpain1 WarsawPoland1 MainzGermany1 A CoruñaSpain1 KatowicePoland1 AlicanteSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00615459 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.